<DOC>
	<DOCNO>NCT02641860</DOCNO>
	<brief_summary>Evaluate safety efficacy Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy Knee Osteoarthritis .</brief_summary>
	<brief_title>Clinical Trial Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy Knee Osteoarthritis</brief_title>
	<detailed_description>A Phase I , Randomized , Single-centered , Double-blinded Clinical Trial Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy Knee Osteoarthritis . This randomized , single-blind , double-blinded , phase I clinical trial . Subjects clinical diagnosis knee osteoarthritis cartilage defect randomly distribute 1:1:1 different dosage group sign ICF screen tests.The treatment accept Allogenic ReJoinTM first fourth week.The duration therapy 48 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Object allergic history allergic constitution . Subjects understand sign consent form study . Age : 1870 , male female . Clinical diagnosis degenerative arthritis Radiographic Criteria KellgrenLawrence : Duration pain Grade 4 ( 11point numeric scale ) &gt; 4 month . Course Knee osteoarthritis:6 month 10 year ; The VAS score :38 point . ( data acquisition time stop use analgesic least 3 day ) . The subject allergic history medicine food。 . The subject'BMI 30 . The subject uncontrolled hardtocontrol disease cardiovascular , liver , kidney lung， endocrine system . The subject history malignant tumour . The subject complication disease : systemic rheumatoid arthritis , Chondrocalcinosis articularis， Hemochromatosis，inflammatory arthropathy，avascular necrosis femoral head，Paget 's disease，hemophilic arthropathy，infectional arthritis，Charcot 's disease，villonodular synovitis synovial chondromatosis . The subject severe generalize infectious disease local knee infection 3 month prior trial . The subject disease lower limb may interfere knee evaluation , example fibromyalgia , osphyalgia , lumbar disc protrusion . The subject coagulation disorder . The subject receive arthroscopic surgery intraarticular operation 6 month prior trial . The subject receive intraarticular injection KOA 6 month precede trial . The subject receive aminoglucose chondroitin sulfate 6 month precede trial . The subject plan knee prosthesis within trial . The subject contraindication MRI , include : subject instal heart pacemaker、defibrillator、heart bracket、heart valve prosthesis、metal clip aneurysm surgery、drug infusion device implant vivo、any electronic device implant body（nerve stimulator、bone growth stimulator）、endovascular coil、strainer、ECG monitor、metal suture、shrapnel sand body , plate fixation steel nail fracture Page 4 4 [ DRAFT ] surgery、artificial limb joint、audiphone、artificial cochlea、middle ear shift plant、metallic intraocular foreign body etc； claustrophobia、pregnancy within 3 months、critically ill patient . The subject test positive : HIV , hepatitis virus , syphilis infectious disease . The subject history alcoholism , drug abuse , mental illness 3 year prior trial . The subject participate clinical trial 3 month prior trial . The subject pregnant , lactate plan conceive within next 6 month . The subject unsuitable adverse condition determine investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>